المؤلفون: AnastasiIa S.A., Osmanova D.Z., Alifirova V.M., Titova M.A., Koroleva E.S., Ivanova S.A.

المصدر: Annals of the Russian academy of medical sciences; Vol 74, No 1 (2019); 14-19 ; Вестник Российской академии медицинских наук; Vol 74, No 1 (2019); 14-19 ; 2414-3545 ; 0869-6047 ; 10.15690/vramn741

مصطلحات موضوعية: multiple sclerosis, gene polymorphism, BDNF, SLC1A2, рассеянный склероз, полиморфные варианты, мозговой нейротрофический фактор, переносчик глутамата второго типа

وصف الملف: application/pdf

Relation: https://vestnikramn.spr-journal.ru/jour/article/view/1069/1066; https://vestnikramn.spr-journal.ru/jour/article/view/1069

الاتاحة: https://vestnikramn.spr-journal.ru/jour/article/view/1069
https://doi.org/10.15690/vramn1069

المؤلفون: Geers, L.M., Pozhidaev, I.V., Ivanova, S.A., Freidin, M.B., Cohen, D., Boiko, A.S., Osmanova, D.Z., Fedorenko, O.Y., Touw, D.J., Semke, A.V., Wilffert, B., Bokhan, N.A., Loonen, A.J.M.

المصدر: Geers , L M , Pozhidaev , I V , Ivanova , S A , Freidin , M B , Cohen , D , Boiko , A S , Osmanova , D Z , Fedorenko , O Y , Touw , D J , Semke , A V , Wilffert , B , Bokhan , N A & Loonen , A J M 2017 , ' Association between P-glycoprotein polymorphisms and antipsychotic drug-induced hyperprolactinemia ' , European Neuropsychopharmacology , vol. 27 , no. Supplement 4 , pp. S956 . https://doi.org/10.1016/S0924-977X(17)31689-9

مصطلحات موضوعية: amisulpride, dopamine 2 receptor, endogenous compound, multidrug resistance protein 1, paliperidone, prolactin, risperidone, sulpiride, adult, brain, concentration ratio, DNA polymorphism, drug toxicity, enzyme linked immunosorbent assay, female, gene frequency, gene mutation, genetic model, genotype, human, human cell, hyperprolactinemia, major clinical study, male, membrane, parkinsonism, prevalence, prolactin blood level, prolactin secreting cell, psychosis

وصف الملف: application/pdf

Relation: https://research.rug.nl/en/publications/3bb53218-46ee-470d-84b8-3e5b09ff5825

الاتاحة: https://hdl.handle.net/11370/3bb53218-46ee-470d-84b8-3e5b09ff5825
https://research.rug.nl/en/publications/3bb53218-46ee-470d-84b8-3e5b09ff5825
https://doi.org/10.1016/S0924-977X(17)31689-9
https://pure.rug.nl/ws/files/50464636/1_s2.0_S0924977X17316899_main.pdf

المؤلفون: Pozhidaev, I., Alifirova, V.M., Freidin, M.B., Zhukova, I.A., Fedorenko, O.Y., Osmanova, D.Z., Mironova, Y.S., Wilffert, B., Ivanova, S.A., Loonen, A.J.M.

المصدر: Pozhidaev , I , Alifirova , V M , Freidin , M B , Zhukova , I A , Fedorenko , O Y , Osmanova , D Z , Mironova , Y S , Wilffert , B , Ivanova , S A & Loonen , A J M 2017 , ' Dopamine receptors genes polymorphisms in Parkinson patients with levodopa-induced dyskinesia ' , European Neuropsychopharmacology , vol. 27 , no. Supplement 4 , pp. S590 . https://doi.org/10.1016/S0924-977X(17)31129-X

مصطلحات موضوعية: biological marker, dopamine 2 receptor, dopamine 3 receptor, dopamine 4 receptor, endogenous compound, levodopa, phosphodiesterase I, Abnormal Involuntary Movement Scale, adult, adverse event, analyzer, cohort analysis, data analysis software, DNA extraction, drug metabolism, drug therapy, female, gender, gene frequency, gene mutation, genetic marker, genetic susceptibility, genotype, human, levodopa-induced dyskinesia, major clinical study, male, onset age, oxidative stress, Parkinson disease

وصف الملف: application/pdf

Relation: https://research.rug.nl/en/publications/49c63eae-168b-434c-a8e6-8245566e6df3

الاتاحة: https://hdl.handle.net/11370/49c63eae-168b-434c-a8e6-8245566e6df3
https://research.rug.nl/en/publications/49c63eae-168b-434c-a8e6-8245566e6df3
https://doi.org/10.1016/S0924-977X(17)31129-X
https://pure.rug.nl/ws/files/50464436/1_s2.0_S0924977X1731129X_main.pdf

المؤلفون: Losenkov, I.S., Pozhidaev, I.V., Osmanova, D.Z., Simutkin, G.G.

المصدر: European Neuropsychopharmacology ; volume 27, page S580 ; ISSN 0924-977X

الاتاحة: http://dx.doi.org/10.1016/s0924-977x(17)31114-8
https://api.elsevier.com/content/article/PII:S0924977X17311148?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:S0924977X17311148?httpAccept=text/plain

المؤلفون: Ivanova, S.A., Alifirova, V.M., Pozhidaev, I.V., Fedorenko, O.Y., Osmanova, D.Z., Tiguntsev, V.V., Bokhan, N.A., Zhukova, I.A., Wilffert, B., Loonen, A.J.M.

المصدر: Ivanova , S A , Alifirova , V M , Pozhidaev , I V , Fedorenko , O Y , Osmanova , D Z , Tiguntsev , V V , Bokhan , N A , Zhukova , I A , Wilffert , B & Loonen , A J M 2016 , ' CYP2D6 and catechol-O-methyltransferase gene polymorphisms in Parkinson patients with levodopa-induced dyskinesias ' , European Neuropsychopharmacology , vol. 26 , pp. S656-S657 .

مصطلحات موضوعية: antioxidant, catechol methyltransferase, cytochrome P450 2D6, dopamine, endogenous compound, levodopa, methionine, neurotransmitter, neurotransmitter receptor, phosphodiesterase I, Abnormal Involuntary Movement Scale, adverse drug reaction, clinical trial, codon, data analysis software, disease carrier, disease duration, DNA extraction, dopamine uptake, drug therapy, gene frequency, genetic susceptibility, genotype, human, levodopa-induced dyskinesia, major clinical study, missense mutation, monoamine metabolism, odds ratio, onset age

Relation: https://research.rug.nl/en/publications/014e8ece-6d80-4997-9468-60cc28f28dd2

الاتاحة: https://hdl.handle.net/11370/014e8ece-6d80-4997-9468-60cc28f28dd2
https://research.rug.nl/en/publications/014e8ece-6d80-4997-9468-60cc28f28dd2

المؤلفون: Osmanova, D.Z., Boiko, A.S., Fedorenko, O.Y., Pozhidaev, I.V., Freidin, M.B., Kornetova, E.G., Ivanova, S.A., Wilffert, B., Loonen, A.J.M.

المصدر: Osmanova , D Z , Boiko , A S , Fedorenko , O Y , Pozhidaev , I V , Freidin , M B , Kornetova , E G , Ivanova , S A , Wilffert , B & Loonen , A J M 2016 , ' Gene polymorphism of serotonin receptors and drug-induced hyperprolactinemia in schizophrenic patients ' , European Neuropsychopharmacology , vol. 26 , no. Supplement 2 , pp. S515-S516 . https://doi.org/10.1016/S0924-977X(16)31542-5

مصطلحات موضوعية: atypical antipsychotic agent, dopamine 2 receptor, endogenous compound, prolactin, serotonin 1A receptor, serotonin 1B receptor, serotonin 2A receptor, serotonin 2C receptor, serotonin 3A receptor, serotonin 3B receptor, serotonin 6 receptor, adult, adverse drug reaction, chemical binding, chi square test, controlled study, data analysis software, diagnosis, DNA polymorphism, drug therapy, enzyme linked immunosorbent assay, female, gene activation, gene frequency, gene inactivation, gene mutation, genetic marker, genetic susceptibility, genetic variability, hemizygote

Relation: https://research.rug.nl/en/publications/836dae82-5505-4f1c-8fc5-c3a89f981ff3

الاتاحة: https://hdl.handle.net/11370/836dae82-5505-4f1c-8fc5-c3a89f981ff3
https://research.rug.nl/en/publications/836dae82-5505-4f1c-8fc5-c3a89f981ff3
https://doi.org/10.1016/S0924-977X(16)31542-5

المؤلفون: Pozhidaev, I., Filipenko, M.L., Vyalova, N.M., Voronina, E.N., Osmanova, D.Z., Fedorenko, O.Y., Semke, A.V., Ivanova, S.A.

المصدر: European Neuropsychopharmacology ; volume 26, page S512-S513 ; ISSN 0924-977X

الاتاحة: http://dx.doi.org/10.1016/s0924-977x(16)31537-1
https://api.elsevier.com/content/article/PII:S0924977X16315371?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:S0924977X16315371?httpAccept=text/plain

المؤلفون: Losenkov, I., Pozhidaev, I.V., Osmanova, D.Z., Simutkin, G.G.

المصدر: European Neuropsychopharmacology ; volume 26, page S173-S174 ; ISSN 0924-977X

الاتاحة: http://dx.doi.org/10.1016/s0924-977x(16)31001-x
https://api.elsevier.com/content/article/PII:S0924977X1631001X?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:S0924977X1631001X?httpAccept=text/plain

المؤلفون: Ivanova, S.A., Alifirova, V.M., Pozhidaev, I.V., Fedorenko, O.Y., Osmanova, D.Z., Tiguntsev, V.V., Bokhan, N.A., Zhukova, I.A., Wilffert, B., Loonen, A.J.M.

المساهمون: Methods in Medicines evaluation & Outcomes research (M2O), Reproductive Origins of Adult Health and Disease (ROAHD), PharmacoTherapy, -Epidemiology and -Economics, Real World Studies in PharmacoEpidemiology, -Genetics, -Economics and -Therapy (PEGET)

المصدر: ResearcherID
European Neuropsychopharmacology, 26, S656-S657. ELSEVIER SCIENCE BV

مصطلحات موضوعية: onset age, antioxidant, side effect, endogenous compound, phenotype, neurotransmitter receptor, genotype, adverse drug reaction, prevalence, gene frequency, disease carrier, statistical analysis, single nucleotide polymorphism, dopamine uptake, odds ratio, oxidative stress, human, levodopa, DNA extraction, cytochrome P450 2D6, Abnormal Involuntary Movement Scale, methionine, phosphodiesterase I, data analysis software, missense mutation, levodopa-induced dyskinesia, treatment response, clinical trial, visually impaired person, major clinical study, drug therapy, monoamine metabolism, Parkinson disease, catechol methyltransferase, substitution reaction, dopamine, codon, disease duration, neurotransmitter, genetic susceptibility

URL الوصول: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::08382109854c93ef19f47098e58d290c
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000398568302345&KeyUID=WOS:000398568302345

المؤلفون: Losenkov, I., Pozhidaev, I.V., Osmanova, D.Z., Simutkin, G.G.

المصدر: European Neuropsychopharmacology. Oct2016 Supplement 2, Vol. 26, pS173-S174. 1p.

مصطلحات موضوعية: *GENETIC polymorphisms, *ANTIDEPRESSANTS, *MENTAL depression, *THERAPEUTICS, *MENTAL depression genetics, *PUBLIC health

المؤلفون: Ivanova, S.A., Alifirova, V.M., Pozhidaev, I.V., Fedorenko, O.Y., Osmanova, D.Z., Tiguntsev, V.V., Bokhan, N.A., Zhukova, I.A., Wilffert, B., Loonen, A.J.M.

المصدر: European Neuropsychopharmacology. Oct2016 Supplement 2, Vol. 26, pS656-S657. 1p.

مصطلحات موضوعية: *CATECHOL-O-methyltransferase gene, *GENETIC polymorphisms, *PARKINSON'S disease patients, *DOPA, *DYSKINESIAS, *DRUG side effects

المؤلفون: Pozhidaev, I., Filipenko, M.L., Vyalova, N.M., Voronina, E.N., Osmanova, D.Z., Fedorenko, O.Y., Semke, A.V., Ivanova, S.A.

المصدر: European Neuropsychopharmacology. Oct2016 Supplement 2, Vol. 26, pS512-S513. 1p.

مصطلحات موضوعية: *SCHIZOPHRENIA treatment, *DRUG side effects, *TARDIVE dyskinesia, *GENETIC polymorphisms, *CYTOCHROME P-450, *RUSSIANS, *DISEASES